Dingdang Health Technology Group Ltd.
DNGHF
$0.14
$0.0217.12%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 655.46M | 651.15M | 649.14M | 662.95M | 675.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 655.46M | 651.15M | 649.14M | 662.95M | 675.39M |
| Cost of Revenue | 433.36M | 433.55M | 435.27M | 446.43M | 456.66M |
| Gross Profit | 222.11M | 217.60M | 213.87M | 216.52M | 218.72M |
| SG&A Expenses | 236.39M | 235.41M | 235.28M | 239.49M | 243.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 678.33M | 677.49M | 679.06M | 694.25M | 708.00M |
| Operating Income | -22.86M | -26.34M | -29.91M | -31.30M | -32.62M |
| Income Before Tax | -46.02M | -48.74M | -51.52M | -39.06M | -26.48M |
| Income Tax Expenses | 1.59M | 1.48M | 1.37M | 1.52M | 1.67M |
| Earnings from Continuing Operations | -47.61 | -50.21 | -52.89 | -40.58 | -28.15 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -205.60K | 136.80K | 482.50K | 628.60K | 775.40K |
| Net Income | -47.82M | -50.08M | -52.41M | -39.95M | -27.38M |
| EBIT | -22.86M | -26.34M | -29.91M | -31.30M | -32.62M |
| EBITDA | -17.45M | -20.67M | -23.96M | -25.43M | -26.85M |
| EPS Basic | -0.04 | -0.04 | -0.04 | -0.03 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.04 | -0.04 | -0.04 | -0.03 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 5.24B | 5.27B | 5.29B | 5.30B | 5.32B |
| Average Diluted Shares Outstanding | 5.24B | 5.27B | 5.29B | 5.30B | 5.32B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |